by correcting the OD 630 of microbe suspensions in incubation broth to afford final target inocula.
Drug controls [ciprofloxacin (ICN Biomedicals; IC 50 0.3 μM) for bacteria and amphotericin B (ICN Biomedicals; IC 50 0.75 μM) for fungi] were included in each assay. IC 50 , which is the concentration that kills 50 % of the organisms, was tested in duplicate using three concentrations (20, 4, and 0.8 ug/mL). All organisms were read at either 630 nm using the EL-340 Biokinetics Reader (Bio-Tek Instruments) or 544ex/590em (M. intracellulare, A. fumigatus) using the Polarstar Galaxy Plate Reader (BMG LabTechnologies) prior to and after incubation.
b-Antimalarial assay
Antimalarial activity of the compounds was determined in vitro on chloroquine sensitive (D6, Sierraleon) and resistant (W2, Indochina) strains of Plasmodium falciparum (Walter Reed Army Institute). The 96-well microplates assay is based on evaluation of the effect of the compounds on the growth of an asynchronous culture of P. falciparum, determined by the assay of parasite lactate dehydrogenase (pLDH) activity. The appropriate dilutions of the compounds were prepared in DMSO and added to the cultures of P. falciparum (2% hematocrit, 2% parasitemia) set up in clear flat bottomed 96-well plates. The plates were placed into a humidified chamber and flushed with a gas mixture of 90% N2, 5% CO2, and 5% O2. The cultures were incubated at 37ºC for 48 h. Growth of the parasite in each well was determined by pLDH assay using Malstat reagent. Medium and RBC controls were also set up in each plate. The standard antimalarial agent, chloroquine (Sigma), was used as the positive control. The IC 50 value of chloroquin is 0.05 μM for both clones. DMSO was used as the negative one.
c-Cytotoxicity on Vero cells
The level of toxicity of each compound was determined by measuring the effect on a fibroblast cell line from African monkey kidney (VERO). For primary evaluation, fractions and isolated compounds were screened at three concentrations (4.76, 1.58, and 0.52 μg/mL), using a culture- Pore size silica column (3.9 x 150 mm). Column chromatography: used silica gel (EM Science, 60Å, 230 -400 mesh ASTM). Preparative TLC was performed with Analtech UNIPLATE, Silica Gel GF preparative layer with UV 254, 20 x 20 cm, 1500 microns.
3-Extraction and isolation
Dried and powdered bark (1.2 kg) and leaves (985 g) were separately and successively extracted at room temperature by maceration with hexanes (3 x 4 L), CHCl 3 (3 x 4 L), and MeOH (4 x 4 L). The extracts were dried in vacuo. CHCl 3 bark extract (10.65 g) was fractionated on silica gel 60 CC eluted with hexanes, CHCl 3, and MeOH in a manner of increasing polarities to collect 11 fractions (250 mL each). Fractions 2-6 (3.5 g) were combined and rechromatographed using silica gel 60 CC (100 g, 100 x 40 mm, 15-40 µm; hexanes: CHCl 3 : EtOH) to yield 20 (58.2mg).
HPLC on NP Phenomenex® Semi-Prep Luna Si (250 mm x 10 mm x 5 µm) using hexanes:
MeOH in the ratio 97:3 gave pure 15 (2.3 mg, [α] 27 D +7.0 (c.0.07, CHCl 3 )). Fraction 7 (2.0 g) was fractionated using silica gel CC (100 g, 100 x 40 mm, 15-40 µm; hexanes: 
